Jiangsu Noruis Medical Devices Co., Ltd. is located in the West Taihu Medical Industry Incubation Park (National Medical Device Innovation Park), Changzhou City, Jiangsu Province. The company was jointly invested and established by Jiangsu Yabang Pharmaceutical Group Co., Ltd. and multiple expert teams, and has received support from several projects in Changzhou City and Jiangsu Province. The company operates and manages under a group model, with four wholly-owned subsidiaries including Changzhou Aikangdun Medical Technology Co., Ltd., Changzhou Furite Biotechnology Co., Ltd., and Beijing Jinkangchi Medical Technology Co., Ltd. At present, the company has more than 20 patents and is a comprehensive company integrating R&D, production, sales, as well as the introduction of foreign high-tech medical device technologies and research on their localization.
The company's purpose is to "cherish health, care for life." Centering on the national great health development plan, it focuses on R&D of medical devices and high-value medical consumables in four major fields: "early diagnosis and treatment of malignant tumors," "precision medicine research on geriatric diseases," "urological medicine," and "medical aesthetics." Meanwhile, the company develops new products through cross-border technology transfer cooperation and direct introduction and registration of globally innovative products. The company has established project cooperation relationships with dozens of medical institutions and medical device companies in countries leading in global medical technology, such as Germany, Switzerland, Belgium, the United States, and Israel.
The company has introduced the "cryotherapy pen," a specialized device for medical aesthetics, from the European company United Medical Partners AG (UMP), and has obtained approval; it has introduced the "covered self-expanding urinary tract stent system" product from the Israeli company Allium, and in April 2018 obtained the Class III medical device product registration certificate from the National Medical Products Administration. This project was also included as a key supported project of the China-Israel cooperation special fund of the Ministry of Science and Technology of China.
The innovative medical device independently developed by Noruis for the "positioning system for early diagnosis and treatment of lung cancer" has completed clinical trial research and is about to be launched. The company currently has multiple innovative medical device products under development and application, and has introduced a series of foreign high-end medical device products.
The marketing team is led by domestic and foreign elites with professional backgrounds, and a full-time academic promotion team is composed of dedicated medical experts. Noruis provides a development platform for outstanding talents aspiring to start businesses. Due to the company's rapid business development needs, it is now recruiting with high salaries passionate, ambitious, and challenge-oriented elites to join!
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows